Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 602, pseudogene (ZNF602P), also known as dJ265C24.5, is annotated as a pseudogene, i.e., a non-functional segment of genomic DNA originally derived from a zinc finger protein gene. It does not produce a functional protein and is not considered a therapeutic target. Zinc finger proteins generally act as transcription factors, but as a pseudogene, ZNF602P lacks known biological functions, disease associations, drug interactions, or biomarker relevance[5]. This gene should not be considered a functional receptor, enzyme, transporter, or classical drug target. Its inclusion may indicate a data error or an attempt to reference a different, active zinc finger protein family member.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 602, pseudogene (ZNF602P).